Resources|Podcasts|March 28, 2025
Transformations in Drug Development for Cell and Gene Therapies
Author(s)PPD, Thermo Fisher Scientific
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Related Content
Trending on Pharmaceutical Technology
1
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
2
CPHI Milan 2026: AI and Bioavailability, Part 1
3
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
4
High-Concentration, Low-Volume Subcutaneous Formulation
5